Table 3 Rates of PISP and PRSP plus β-lactamase-positive H. influenzae and BLNAR, regionally and globally
PISP n (%) | PRSP n (%) | BL-Pos HI n (%) | BLNARan (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
2004-08 | 2009-12 | 2004-12 | 2004-08 | 2009-12 | 2004-12 | 2004-08 | 2009-12 | 2004-12 | 2004-08 | 2009-12 | 2004-12 | |
Africa | 67/156 (42.9) | 16/65 (24.6) | 83/221 (37.6) | 40/156 (25.6) | 21/65 (32.3) | 61/221 (27.6) | 13/157 (8.3) | 6/61 (9.8) | 19/218 (8.7) | 4/157 (2.5) | 1/61 (1.6) | 5/218 (2.3) |
Asia/ Pacific Rim | 152/689 (22.1) | 42/296 (14.2) | 194/985 (19.7) | 198/689 (28.7) | 98/296 (33.1) | 296/985 (30.1) | 192/688 (27.9) | 83/302 (27.5) | 275/990 (27.8) | 23/688 (3.3) | 12/302 (4.0) | 35/990 (3.5) |
Europe | 536/2786 (19.2) | 559/2983 (18.7) | 1095/5769 (19.0) | 295/2786 (10.6) | 302/2983 (10.1) | 597/5769 (10.3) | 436/3011 (14.5) | 499/3311 (15.1) | 935/6322 (14.8) | 56/3011 (1.9) | 45/3311 (1.3) | 101/6322 (1.6) |
Latin America | 226/771 (29.3) | 139/397 (35.0) | 365/1168 (31.3) | 105/771 (13.6) | 60/397 (15.1) | 165/1168 (14.1) | 154/747 (20.6) | 84/410 (20.5) | 238/1157 (20.6) | 8/747 (1.1) | 12/410 (2.9) | 20/1157 (1.7) |
Middle East | 54/182 (29.7) | 87/278 (31.3) | 141/460 (30.7) | 43/182 (23.6) | 70/278 (25.2) | 113/460 (24.6) | 42/210 (20.0) | 53/281 (18.9) | 95/491 (19.3) | 1/210 (0.5) | 4/281 (1.4) | 5/491 (1.0) |
North America | 1180/4280 (27.6) | 316/1555 (20.3) | 1496/5835 (25.6) | 646/4280 (15.1) | 254/1555 (16.3) | 900/5835 (15.4) | 1015/3919 (25.9) | 410/1673 (24.5) | 1425/5592 (25.5) | 40/3919 (1.0) | 22/1673 (1.3) | 62/5592 (1.1) |
Global | 2215/8864 (25.0) | 1159/5574 (20.8) | 3374/14438 (23.4) | 1327/8864 (15.0) | 805/5574 (14.4) | 2132/14438 (14.8) | 1852/8732 (21.2) | 1135/6038 (18.8) | 2987/14770 (20.2) | 132/8732 (1.5) | 96/6038 (1.6) | 228/14770 (1.5) |